March 29, 2018
Written by
Founder & CFO
Share this article
On March 29th, 2018 Anneke Sijbers received Enzyre’s award of € 10,000 during a MedtechPartners meeting celebrating their 10-year anniversary.
Enzyre is now preparing to raise €10M in its Series A investment round. The proceeds will be used to (a) finalize the development of the ENZYPAD en ENZYCARD Hemophilia A, (b) manufacture the portable instrument & disposable, and (c) perform studies to obtain regulatory approval in EU & US. The product will be commercialized worldwide through our pharma partner. Interested candidate investors are encouraged to contact us at investors@enzyre.com.
Get involved
Enzyre BV
Transistorweg 5
6534-AT Nijmegen
The Netherlands
